Catalonia Overhauls Healthcare with 30 New Integrated Health Areas
Catalonia's health department replaces 43 outdated management areas with 30 Integrated Health Areas (AIS) to prioritize primary care, tackle ageing.
Key Points
- Replaces 43 old areas with 30 AIS based on demographics, social factors, and mobility.
- Aims to center primary care, address ageing, chronic diseases, and staff shortages.
- Pilot tests start March for one year to test integrated care models.
- Junts MP Fàbrega welcomes but flags gaps in social/pharmacy inclusion and regional splits like Garrotxa.
Catalonia's health department unveiled a major overhaul of its healthcare system on Wednesday, creating 30 Integrated Health Areas (AIS) to replace the existing 43 management areas, which date back 18 years. The restructuring aims to place primary care at the centre while addressing challenges like population ageing, rising chronic diseases, and staff shortages to ensure the model's sustainability.
Aina Plaza, the director general of Health Planning, said the new areas were designed using demographic, social, and mobility criteria. They will strengthen collaboration between hospitals, home care, and community mental health services. Pilot tests are set to launch in March and run for a year to evaluate integrated care models.
Junts per Catalunya MP Jordi Fàbrega, the party's spokesperson on the Catalan parliament's Health Committee, welcomed the review as timely but called it a missed opportunity. He argued the AIS should have incorporated social resources, such as residential care facilities, and involved the pharmacy sector more deeply to shift focus from treating illness to promoting health.
Despite giving the system a vote of confidence to see how it performs, Fàbrega expressed concern over some area divisions. Representing Lleida, the Alt Pirineu, and Aran, he questioned the mobility rationale for grouping Alta Ribagorça with the two Pallars areas. He also raised doubts about the split in the Garrotxa region, which separates Ripollès from Camprodon and Garrotxa. "We'll see how it impacts Campdevànol Hospital," he said, noting assurances of no effect but warning that a potential 3% drop in users could still have consequences.
Original Sources
This article was aggregated from the following Catalan-language sources: